v3.26.1
Organization and Description of Business (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 18 Months Ended
Mar. 19, 2026
USD ($)
$ / shares
shares
Apr. 28, 2025
Employee
Sep. 24, 2024
USD ($)
$ / shares
May 31, 2026
Employee
Mar. 31, 2026
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
shares
Mar. 31, 2026
USD ($)
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
Mar. 27, 2025
$ / shares
Subsidiary, Sale of Stock [Line Items]                  
Accumulated deficit         $ (744,467)   $ (744,467) $ (726,848)  
Operating losses         28,935 $ 23,184      
Net cash flows used in operating activities         $ 25,104 $ 28,601      
Common stock, par value (in dollars per share) | $ / shares         $ 0.0001   $ 0.0001 $ 0.0001  
Price per share | $ / shares                 $ 2
Cash and cash equivalents         $ 48,539   $ 48,539 $ 50,497  
Reduction in workforce | Employee   30              
Forecast                  
Subsidiary, Sale of Stock [Line Items]                  
Reduction in workforce | Employee       45          
Equity Line Financing                  
Subsidiary, Sale of Stock [Line Items]                  
Common stock, par value (in dollars per share) | $ / shares     $ 0.0001            
Common stock purchase agreement, amount authorized     $ 50,000            
Common stock purchase agreement, term     24 months            
Common stock purchase agreement, amount remaining         $ 47,500   $ 47,500    
Number of shares issued (in shares) | shares         0 0 500,000    
March 2026 Registered Direct Offering                  
Subsidiary, Sale of Stock [Line Items]                  
Number of shares issued (in shares) | shares 25,000,000                
Price per share | $ / shares $ 0.8                
Net proceeds from sale of stock $ 18,300